Skip to content
ClinCalc Pro
Menu
IV Corticosteroid / Adrenal Replacement

Hydrocortisone (IV — Paediatric Emergency)

Brand names: Solu-Cortef

Intravenous hydrocortisone for paediatric emergencies, used as glucocorticoid (and mineralocorticoid) replacement in adrenal crisis and as treatment in severe acute conditions such as anaphylaxis and acute severe asthma.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

A glucocorticoid that binds intracellular corticosteroid receptors to modulate gene transcription, producing broad anti-inflammatory and immunosuppressive effects and, in deficiency, restoring physiological cortisol activity.

Prescribing in practice

  • In suspected adrenal crisis, parenteral hydrocortisone must be given without delay and not withheld pending investigations, as untreated crisis is rapidly life-threatening.
  • It is an adjunct in anaphylaxis and acute severe asthma and must never replace adrenaline or oxygen and bronchodilators as first-line treatment.
  • Confirm emergency paediatric dosing by age against local resuscitation guidance and a children's formulary.

Monitoring

Monitor blood glucose, blood pressure, fluid balance and electrolytes during emergency treatment and arrange appropriate follow-up of the underlying cause.

Counselling the patient

  • Ensure families of children with adrenal insufficiency know the sick-day rules and emergency injection plan.
  • Advise carrying a steroid emergency card or alert where adrenal insufficiency is known.
  • Explain that emergency steroid is being given to support the child's stress response.

Evidence & guidelines

Parenteral hydrocortisone is standard emergency management of adrenal crisis and an established adjunct in anaphylaxis and acute asthma per resuscitation and endocrine guidance.

Reference: BSPED Guidelines; Society for Endocrinology Emergency Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.